Who owns Twist Bioscience Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TWST from SEC Form 13F filings across 338 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 338 institutions disclosed 76.4M shares of Twist Bioscience Corp worth $7.85B — about 122.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
338
13F holders
$7.85B
value, 2026 filers
122.4%
of shares outstanding (76.4M sh)
92
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TWST's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.8M | $600.2M | 0.0% | 9.3% | +5.0% |
| 2 | Artisan Partners Limited Partnership | 4.8M | $494.0M | 0.8% | 7.7% | -24.6% |
| 3 | FMR LLC | 4.7M | $483.8M | 0.0% | 7.5% | +148.8% |
| 4 | ARK Investment Management LLC | 4.5M | $468.1M | 3.0% | 7.3% | -28.3% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.6M | $373.9M | 0.0% | 5.8% | +5069.8% |
| 6 | STATE STREET CORP | 3.2M | $332.6M | 0.0% | 5.2% | -11.9% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.8M | $290.6M | 0.0% | 4.5% | +6.6% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $277.7M | 0.0% | 4.3% | +2.3% |
| 9 | EdgePoint Investment Group Inc. | 2.5M | $259.4M | 2.0% | 4% | -53.2% |
| 10 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.2M | $223.7M | 0.7% | 3.5% | -58.7% |
| 11 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.1M | $219.8M | 1.0% | 3.4% | +49.6% |
| 12 | Invesco Ltd. | 1.9M | $198.4M | 0.0% | 3.1% | -11.2% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $166.6M | 0.0% | 2.6% | +6.6% |
| 14 | Thrivent Financial for Lutherans | 1.4M | $147.5M | 0.2% | 2.3% | +9.2% |
| 15 | GOLDMAN SACHS GROUP INC | 1.4M | $144.9M | 0.0% | 2.3% | -17.4% |
| 16 | MORGAN STANLEY | 1.2M | $122.4M | 0.0% | 1.9% | +117.6% |
| 17 | D. E. Shaw & Co., Inc. | 1.2M | $122.0M | 0.1% | 1.9% | +2441.8% |
| 18 | BAILLIE GIFFORD & CO | 1.1M | $111.8M | 0.1% | 1.7% | -10.6% |
| 19 | Driehaus Capital Management LLC | 1.0M | $105.2M | 0.6% | 1.6% | +74.9% |
| 20 | Sumitomo Mitsui Trust Group, Inc. | 1.0M | $102.9M | 0.1% | 1.6% | -33.1% |
| 21 | Amova Asset Management Americas, Inc. | 999,734 | $102.8M | 1.3% | 1.6% | -33.2% |
| 22 | BANK OF AMERICA CORP /DE/ | 922,647 | $94.9M | 0.0% | 1.5% | +57.9% |
| 23 | CITADEL ADVISORS LLC | 862,042 | $88.7M | 0.0% | 1.4% | -29.4% |
| 24 | LOOMIS SAYLES & CO L P | 861,309 | $88.6M | 0.1% | 1.4% | +75.0% |
| 25 | Stephens Investment Management Group LLCNEW | 767,364 | $78.9M | 0.8% | 1.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.